Effect of Qili Qiangxin Capsule on Adenosine Content in Chronic Heart Failure Rats with Insufficiency of Heart-Qi

YU Chun-quan; LI Xin-tong; SHI Fang; XIAO Yang; WANG Yi

您当前的位置：

首页 >

文章列表页 >

Effect of Qili Qiangxin Capsule on Adenosine Content in Chronic Heart Failure Rats with Insufficiency of Heart-Qi

更新时间：2024-01-04

- Effect of Qili Qiangxin Capsule on Adenosine Content in Chronic Heart Failure Rats with Insufficiency of Heart-Qi
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 3, Pages: 174-177(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
YU Chun-quan, LI Xin-tong, SHI Fang, et al. Effect of Qili Qiangxin Capsule on Adenosine Content in Chronic Heart Failure Rats with Insufficiency of Heart-Qi[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(3): 174-177.
DOI：

YU Chun-quan, LI Xin-tong, SHI Fang, et al. Effect of Qili Qiangxin Capsule on Adenosine Content in Chronic Heart Failure Rats with Insufficiency of Heart-Qi[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(3): 174-177. DOI：

摘要

目的: 观察芪苈强心胶囊对心气虚型慢性心衰大鼠缺血心肌中腺苷酸含量的影响。方法: 采用结扎大鼠冠状动脉左前降支

心肌梗死8周后形成心气虚型慢性心力衰竭模型

随机分为假手术组、模型组、芪苈强心胶囊高、中、低(1.0

0.5

0.25 g ·kg-1)剂量组、缬沙坦20 mg ·kg-1组。连续给药4周后

利用高效液相色谱法

检测大鼠心脏缺血心肌中ATP

ADP

AMP含量

计算能荷。结果: 模型组大鼠心肌组织中ATP

ADP

AMP含量分别由(8.96±2.68)

(63.66±14.34)

(201.6±66.80)mg ·g-1下降至(5.75±1.19)

(48.4±15.62)

(133.4±54.53) mg ·g-1

与假手术组比较具有显著差异(P<0.01)

芪苈强心胶囊高剂量组能明显增加缺血心肌中ATP含量

提高能荷

与模型组比较有明显差异(P<0.05)。结论: 芪苈强心胶囊可增加缺血心肌组织中腺苷酸含量

从而改善心肌梗死后心衰大鼠心肌能量代谢。

Abstract

Objective: To observe the effect of Qili Qiangxin capsule on the content of adenosine triphosphate (ATP)

adenosine diphosphate (ADP)

adenosine monophosphate (AMP) in myocardium of heart failure rats. Method: The anterior descending coronary artery was ligated to result in myocardial infarction and establish congestive heart failure (CHF) model with insufficiency of Heart-Qi. After 8 weeks symptoms of insufficiency of Heart-Qi appeared. Rats were randomly divided into sham operation group

model group

Qili Qiangxin capsule groups with dose of 0.25

0.5

1.0 g ·kg-1 and valsartan group. After 4 weeks of continuous administration

high performance liquid chromatography(HPLC) was used to detect the content of ATP

ADP

AMP in ischemia myocardium

and the energy charge was calculated. Result:Compared with sham group

the content of ATP

ADP

AMP in myocardium was obviously decreased in model group(P<0.01). Compared with model group

the content of ATP in high dose group of Qili Qiangxin capsule was obviously increased(P<0.05). The high dose group of Qili Qiangxin capsule could increase the energy charge (P<0.05

compared with the model group). Conclusion: Qili Qiangxin capsule can effectively inhibit the obstacle of energy metabolism and protect the cardiac function by up-regulation the contents of ATP.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Qili Qiangxin Capsule on Cardiac Function and Levels of Brain Natriuretic Peptide in Patients with Chronic Systolic Heart Failure

Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure

Effect of Qingxin Jieyu Granules Regulating Mitophagy on Ventricular Remodeling After Myocardial Infarction of C57B/L6 Mice

Material Basis and Its Distribution in vivo of Qili Qiangxin Capsules Analyzed by UPLC-Q-Orbitrap-MS

Effect of Serum Containing Zhenwutang on Apoptosis of Myocardial Mast Cells and Mitochondrial Autophagy

Related Author

HUANG Bin

CHEN Yu

WANG Maolin

WANG Yun

ZHAO Yifan

XU Jing

WU Hongwei

WANG Fang

Related Institution

Jiangxi University of Chinese Medicine

Center for Food Evaluation，State Administration for Market Regulation

Jiangxi Province Key Laboratory of Traditional Chinese Medicine（TCM） Pharmacology，Institute of TCM Health Industry，China Academy of Chinese Medical Sciences

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

Research Institute of Integrated Chinese and Western Medicine， Fujian University of Traditional Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰